Portable neonatal warming device restores normothermia, reduces neonatal unit admissions, and supports family centred care across UK hospitals.

Neonatal hypothermia presents a critical challenge in the care of preterm infants, whose underdeveloped thermoregulatory systems render them particularly vulnerable to environmental temperature ...

Table 1. Summary of Initial Clinical Trials; Seminal Work From 3 Primary Research Teams Citation Sample Size/Inclusion Criteria Method/Duration of Cooling Follow-up Findings 27 234 term infants; 116 ...

Whole-body hypothermia within hours of birth failed to improve outcomes in preterm infants less than 36 weeks' gestational age with hypoxic-ischemic encephalopathy. Death or moderate or severe ...

Hypoxic-ischemic encephalopathy (HIE) is one of the leading causes of newborn mortality and morbidity worldwide, and lowering the baby’s body temperature—called therapeutic hypothermia—is often used ...

Adding a high dose of erythropoietin to therapeutic hypothermia did not reduce rates of death or disability in infants with neonatal hypoxic ischemic encephalopathy (HIE), a phase III randomized trial ...

<1000 g/25 wk (+/−2) gestation, born at study center Polyethylene bag while infant wet immediately after birth •Higher temperature on admission and at one hour of life in the wrap group (36°C/96.8°F) ...

The therapeutic hypothermia systems market grows with rising cardiac and neurological cases, surgical demand, and adoption of advanced cooling devices. BRENTFORD ...

Erythropoietin, a treatment for newborns with critically low levels of oxygen or blood supply to the brain at birth, does not prevent death or disability, according to a new multinational study. The ...